UPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light
Go back to UPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 32.20 +0.72 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.48 | 52 Week High | $66.55 | |||
| Open | $31.37 | 52 Week Low | $37.82 | |||
| Day High | $32.39 | P/E | N/A | |||
| Day Low | $31.28 | EPS | $0.00 | |||
| Volume | 6,110,958 | |||||
